Physician profile
Michael A Greene
NPI 1811215254
$72,940.08
in general payments reported to CMS, 2019-2025
59 companies · $10K in 2025
The $10K reported for 2025 was more than what 97% of Pain Medicine (Physical Medicine & Rehabilitation) providers received nationally (typical 2025 total: $400).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $11K · 2020: $2,167 · 2021: $14K · 2022: $4,359 · 2023: $11K · 2024: $20K · 2025: $10K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $13K · Food and Beverage: $13K · Travel and Lodging: $9,268 · Consulting Fee: $6,668.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $12,857.50 |
| Food and Beverage | $12,662.28 |
| Travel and Lodging | $9,267.61 |
| Consulting Fee | $6,668.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $21,883.43 | 2021-2025 | Intellis Adaptivestim, Inceptiv, Unid_pass |
| Biodelivery Sciences International, INC. | $20,733.78 | 2019-2021 | |
| Vertos Medical, INC. | $11,770.98 | 2022-2024 | Mild Device Kit |
| Spinal Simplicity, LLC | $3,741.06 | 2023-2025 | Ha Minuteman G3-R |
| Vertiflex, INC. | $2,206.13 | 2019 | |
| Boston Scientific Corporation | $1,595.83 | 2019-2025 | Intracept, General - Pain Management, Wavewriter Alpha Prime 16 |
| Medtronic USA, INC. | $1,497.46 | 2019 | |
| Abbvie INC. | $1,046.90 | 2021-2025 | |
| Collegium Pharmaceutical, INC. | $1,031.37 | 2019-2025 | Xtampza, Belbuca |
| Stryker Corporation | $1,000.00 | 2024 | Mild Device Kit |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $740.13 | 2019-2025 | Relistor |
| Foundation Fusion Solutions, LLC | $675.78 | 2023-2025 | |
| Spr Therapeutics, INC | $639.48 | 2020-2025 | Sprint Pns System |
| Abbott Laboratories | $607.51 | 2020-2025 | Proclaim, Eterna |
| Painteq LLC | $493.49 | 2021-2024 | Painteq |
Show all 59 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Nalu Medical, INC. | $417.89 | 2022-2024 | Nalu Neurostimulation System |
| Amgen INC. | $335.21 | 2019-2022 | |
| Nevro Corp. | $196.96 | 2019-2020 | |
| Relievant Medsystems, INC. | $187.41 | 2021-2023 | Intracept |
| Saluda Medical Americas, INC. | $169.86 | 2023-2025 | Evoke, Evoke Scs |
| Lilly USA, LLC | $141.20 | 2022-2024 | Emgality |
| Almatica Pharma LLC | $134.58 | 2021-2023 | Gralise |
| Ferring Pharmaceuticals INC. | $126.78 | 2020-2023 | Euflexxa |
| Protega Pharmaceutials INC | $125.81 | 2023-2025 | Roxybond |
| Zyla Life Sciences, INC. | $115.64 | 2019 | |
| Tersera Therapeutics LLC | $92.20 | 2019-2024 | Prialt |
| Biohaven Pharmaceutical Holding Company LTD. | $87.13 | 2022 | |
| Teva Pharmaceuticals USA, INC. | $84.65 | 2019-2020 | |
| Abiomed | $78.86 | 2025 | |
| Forte Bio-Pharma LLC | $69.06 | 2024-2025 | Prolate, Nalocet, Tanlor |
| Azurity Pharmaceuticals, INC. | $65.82 | 2023-2025 | Horizant, Horizant |
| Alevio, LLC | $63.15 | 2023 | Sicure Sacroiliac Joint Fusion System |
| Valinor Pharma, LLC | $62.79 | 2024-2025 | Movantik |
| Globus Medical, INC. | $57.75 | 2025 | Senza |
| Pfizer INC. | $51.35 | 2019-2023 | |
| Novartis Pharmaceuticals Corporation | $51.33 | 2019 | |
| Allergan, INC. | $48.21 | 2019-2020 | |
| Arbor Pharmaceuticals, INC. | $47.34 | 2019-2021 | |
| Curonix LLC | $37.36 | 2023-2024 | Pns Freedom-4a Permanent Neurostimulator Receiver Kit Channel A |
| Assertio Therapeutics, INC. | $37.30 | 2019 | |
| Hikma Pharmaceuticals USA | $35.00 | 2022 | |
| Lundbeck LLC | $26.93 | 2023 | Vyepti |
| Bioventus LLC | $26.67 | 2025 | Durolane |
| Indivior INC. | $24.87 | 2019 | |
| Depuy Synthes Sales INC. | $23.89 | 2019 | |
| Braeburn INC. | $23.86 | 2024 | Brixadi |
| Astrazeneca Pharmaceuticals LP | $23.78 | 2019-2020 | |
| Si-Bone, INC. | $23.24 | 2023 | |
| Stimwave Technologies Incorporated | $22.76 | 2019-2022 | |
| Orthogenrx INC. | $19.70 | 2021 | |
| Takeda Pharmaceuticals U.S.A., INC. | $19.54 | 2019 | |
| Idorsia Pharmaceuticals US INC | $17.40 | 2023 | Quviviq |
| Fidia Pharma USA INC. | $16.83 | 2020 | |
| Shionogi INC | $15.75 | 2019 | |
| Amneal Pharmaceuticals LLC | $15.71 | 2023 | Lyvispah |
| Biogen, INC. | $15.62 | 2021 | |
| Scilex Pharmaceuticals INC. | $14.61 | 2021 | |
| Horizon Therapeutics Plc | $13.32 | 2019 | |
| Mdd US Operations, LLC | $11.63 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Greene listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.